These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22220931)

  • 21. Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during World Cup Soccer 2006.
    Wilbert-Lampen U; Nickel T; Leistner D; Güthlin D; Matis T; Völker C; Sper S; Küchenhoff H; Kääb S; Steinbeck G
    J Am Coll Cardiol; 2010 Feb; 55(7):637-42. PubMed ID: 20170788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial.
    Tahir M; Foley B; Pate G; Crean P; Moore D; McCarroll N; Walsh M
    Am Heart J; 2005 Aug; 150(2):302-6. PubMed ID: 16086935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine?
    Fan FL; Dart AM
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):404-5. PubMed ID: 22524858
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina.
    Bauer T; Möllmann H; Weidinger F; Zeymer U; Seabra-Gomes R; Eberli F; Serruys P; Vahanian A; Silber S; Wijns W; Hochadel M; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2011 Sep; 151(2):164-9. PubMed ID: 20605241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
    Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
    Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M
    J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use.
    Hoskins MH; Leleiko RM; Ramos JJ; Sola S; Caneer PM; Khan BV
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):47-52. PubMed ID: 20133495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
    Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
    Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of widespread inflammation after contemporary PCI.
    Tiong AY; Lowe HC; Freedman SB; Brieger DB
    Int J Cardiol; 2010 Apr; 140(1):82-7. PubMed ID: 19042046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Xinmaitong capsule on serum matrix metalloproteinases-9, high sensitive C-reactive protein levels in patients with acute coronary syndrome].
    Meng J; Qin J; Ma Y; Sun HM; Luo CF; Qiu RX
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):850-2. PubMed ID: 17639992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
    Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of beta-adrenoblocking therapy on the markers of systemic inflammation in patients with acute coronary syndrome].
    Sisakian AS; Davtian AR; Pepoian SK; Oganesian AS
    Klin Med (Mosk); 2011; 89(4):56-9. PubMed ID: 21932567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
    Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.
    Kereiakes DJ
    Circulation; 2003 Oct; 108(16 Suppl 1):III22-7. PubMed ID: 14605016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G; Chello M; Pasceri V; Colonna D; Nusca A; Miglionico M; D'Ambrosio A; Covino E; Di Sciascio G
    J Am Coll Cardiol; 2006 Oct; 48(8):1560-6. PubMed ID: 17045888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.